JP2021012738A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021012738A5 JP2021012738A5 JP2020177056A JP2020177056A JP2021012738A5 JP 2021012738 A5 JP2021012738 A5 JP 2021012738A5 JP 2020177056 A JP2020177056 A JP 2020177056A JP 2020177056 A JP2020177056 A JP 2020177056A JP 2021012738 A5 JP2021012738 A5 JP 2021012738A5
- Authority
- JP
- Japan
- Prior art keywords
- knowledge
- medical document
- entry
- management system
- case
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000024891 symptom Diseases 0.000 claims description 128
- 201000010099 disease Diseases 0.000 claims description 99
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 99
- 238000009826 distribution Methods 0.000 claims description 12
- 230000006870 function Effects 0.000 claims description 12
- 230000002776 aggregation Effects 0.000 claims description 8
- 238000004220 aggregation Methods 0.000 claims description 8
- 230000008676 import Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 description 16
- 206010012601 diabetes mellitus Diseases 0.000 description 15
- 238000003745 diagnosis Methods 0.000 description 14
- 238000012545 processing Methods 0.000 description 13
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 11
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 11
- 201000001421 hyperglycemia Diseases 0.000 description 10
- 238000012360 testing method Methods 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 208000007107 Stomach Ulcer Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 201000005917 gastric ulcer Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000004020 conductor Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 208000002682 Hyperkalemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 230000004931 aggregating effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000007345 glycogen storage disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000000575 Arteriosclerosis Obliterans Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000027790 Rib fracture Diseases 0.000 description 1
- 101710195583 Urinary protein 2 Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000021754 continuous fever Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000030133 remittent fever Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020177056A JP7008939B2 (ja) | 2020-10-22 | 2020-10-22 | 医療文書管理システム |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020177056A JP7008939B2 (ja) | 2020-10-22 | 2020-10-22 | 医療文書管理システム |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018127518A Division JP6913308B2 (ja) | 2018-07-04 | 2018-07-04 | 医療文書管理システム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021012738A JP2021012738A (ja) | 2021-02-04 |
| JP2021012738A5 true JP2021012738A5 (enExample) | 2021-08-19 |
| JP7008939B2 JP7008939B2 (ja) | 2022-01-25 |
Family
ID=74226543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020177056A Active JP7008939B2 (ja) | 2020-10-22 | 2020-10-22 | 医療文書管理システム |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7008939B2 (enExample) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5207810B2 (ja) | 2008-04-22 | 2013-06-12 | 株式会社日立製作所 | 用語入力支援装置及び方法、並びにプログラム |
| JP6808422B2 (ja) | 2016-09-27 | 2021-01-06 | キヤノン株式会社 | 医用情報処理装置、医用情報処理システム、医用情報処理方法およびプログラム |
-
2020
- 2020-10-22 JP JP2020177056A patent/JP7008939B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6913308B2 (ja) | 医療文書管理システム | |
| Dohan et al. | Using computers to analyze ethnographic field data: Theoretical and practical considerations | |
| CN104769588B (zh) | 队列识别系统 | |
| JP6792750B2 (ja) | 診断支援システム | |
| JP6814482B2 (ja) | 知識管理システム | |
| Zhou et al. | Clinical decision support system for hypertension medication based on knowledge graph | |
| JP7083977B2 (ja) | 知識管理システム | |
| Khan et al. | Towards development of health data warehouse: Bangladesh perspective | |
| JP2021077382A5 (enExample) | ||
| JP6868860B2 (ja) | 知識管理システム | |
| Zhang et al. | Cross-standard health data harmonization using semantics of data elements | |
| Grandi et al. | Efficient management of multi-version clinical guidelines | |
| JP2020129385A5 (enExample) | ||
| Levchenko et al. | Enabling preprint discovery, evaluation, and analysis with Europe PMC | |
| Leroux et al. | Using CDISC ODM and the RDF Data Cube for the Semantic Enrichment of Longitudinal Clinical Trial Data. | |
| del Mar Roldán-García et al. | Towards an ontology-driven clinical experience sharing ecosystem: Demonstration with liver cases | |
| JP7008939B2 (ja) | 医療文書管理システム | |
| JP2021012738A5 (enExample) | ||
| Schulman | Managing your patients' data in the neonatal and pediatric ICU: an introduction to databases and statistical analysis | |
| Goralwalla et al. | Modeling medical trials in pharmacoeconomics using a temporal object model | |
| Scharnhorst et al. | Looking at a digital research data archive-Visual interfaces to EASY | |
| Branescu et al. | Solutions for medical databases optimal exploitation | |
| Panesar | Preparing Data | |
| Schuler et al. | An asset management approach to continuous integration of heterogeneous biomedical data | |
| Miller et al. | The use of relational databases as a tool for conducting clinical studies |